Biotechnology SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reata Pharmaceuticals, Inc. – RETA August 12, 2020
Biotechnology BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) August 12, 2020
Biotechnology Ascendis Pharma A/S Receives Orphan Designation for TransCon(TM) CNP for the Treatment of Achondroplasia in Europe August 12, 2020
Biotechnology RETA INVESTIGATION: Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Reata Pharmaceuticals, Inc. Investigation August 11, 2020
Biotechnology BridgeBio Pharma, Inc. Reports Second Quarter 2020 Financial Results and Business Update August 11, 2020
Biotechnology BridgeBio Pharma Expands Reach Into China and Other Major Asian Markets Through Strategic Collaboration With Perceptive Advisors-Founded Company, LianBio August 11, 2020
Search
biotech sector etf
